Sanofi, Translate Bio mRNA Covid-19 vaccine candidate induced high antibody levels in preclinical studies
Preclinical evaluation of MRT5500, importantly, demonstrated a favorable immune response profile against SARS-CoV-2. These data support the selection of MRT5500 for clinical development. A Phase 1/2 clinical trial